Frequently asked questions

Substances that may improve cognitive function, memory, focus, mood, creativity, or motivation, while having a low side-effect profile. The term was coined in 1972 by Romanian chemist Corneliu Giurgea, who set strict criteria: a true nootropic should enhance learning, protect the brain, lack significant side effects, and not act like a typical stimulant or sedative. Modern usage is looser: today the word covers anything from caffeine and L-theanine to prescription drugs like modafinil and methylphenidate to research peptides. We use the broad definition on this site while flagging which compounds belong to which legal and risk category.

Safety varies enormously by substance, dose, combination, and individual physiology. We grade each substance on a 0-5 safety scale informed by clinical literature and adverse-event profiles. A 5 means the compound is tolerated by almost everyone at recommended doses (caffeine, L-theanine, omega-3, ashwagandha at typical doses). A 1-2 means the compound has serious dependence, cardiovascular, or hepatotoxicity risk (phenibut, yohimbine at high doses, kava with chronic use). Always consult a healthcare provider before starting any new compound, especially if you take prescription medication or have an existing medical condition.

Legal status varies by country and by substance, we track US, UK, EU, and Australian status on every substance page. Most adaptogens, amino acids, and many over-the-counter compounds (caffeine, L-theanine, omega-3, ashwagandha, magnesium) are unscheduled and freely available in all four jurisdictions. Some popular nootropics are prescription-only: modafinil and methylphenidate are scheduled in the US, prescription in the UK/EU/AU. Racetams (piracetam, aniracetam, oxiracetam) are unscheduled in the US but prescription-only in most of the EU and Australia. A few compounds are explicitly banned or restricted as dietary supplements (phenibut in the US, vinpocetine in the US since 2019). Always verify the legal status in your jurisdiction before purchasing.

We grade evidence A-F based on the quantity and quality of human research supporting each claim. Grade A means multiple well-powered randomized controlled trials with consistent results, caffeine, L-theanine, omega-3, ashwagandha, vitamin D3, and creatine all earn A grades for their primary indications. Grade B means moderate evidence, typically a handful of RCTs, sometimes mixed, often with smaller sample sizes (bacopa, alpha-GPC, lion's mane, rhodiola). Grade C means limited human evidence relying heavily on animal or mechanistic data (most peptides, newer compounds like fisetin). Grade D and F are reserved for claims unsupported by human data. The grade reflects the evidence for the specific benefit listed, not the substance overall, caffeine has Grade A for vigilance but only Grade C for memory.

Safety is a 0-5 score combining tolerability at typical doses, severity of side effects, dependence and abuse potential, and interaction profile. Score 5 means broadly safe for most adults at recommended doses (L-theanine, magnesium glycinate, omega-3). Score 4 means generally safe with predictable mild side effects or specific contraindications (caffeine, alpha-GPC). Score 3 means real risks that require attention (modafinil, methylphenidate, huperzine A with chronic use). Score 2 means significant risk profile that limits routine use (yohimbine, amphetamine, kava). Score 1 means dependence, severe withdrawal, or major toxicity (phenibut). Scores are conservative and assume responsible use; misuse changes the calculus.

All substance entries, stacks, guides, and comparison pages are written by the Nootropics.com editorial team and reviewed against current clinical literature. We cite primary research whenever possible (PubMed IDs in the citations field on each substance). Our editorial rubric is the same across the catalog, we will publish negative findings about a popular substance, an underperforming stack, or a vendor we have a commercial relationship with. Sponsored reviews follow the same rubric and are clearly labelled. If you spot an error or have research we should consider, email [email protected], we update pages on receipt of credible corrections.

The safest entry points for most adults are: caffeine 100mg + L-theanine 200mg in the morning for focus, omega-3 (≥1000mg combined EPA+DHA) with a meal for long-term brain health, and magnesium L-threonate or glycinate before bed for sleep. Add one substance at a time, hold the dose for at least three days before adjusting, and track focus, mood, energy, and sleep on a 1-10 scale daily. Skip the racetams, peptides, and prescription compounds for the first 90 days, there is no nootropic that meaningfully outperforms adequate sleep, daily exercise, and the foundations above. Use our Goal Finder tool for a personalised starter stack.

A stack is a deliberate combination of two or more substances chosen for complementary mechanisms. The most-validated stack in the literature is caffeine + L-theanine in a 1:2 ratio. Stacks make sense when individual ingredients address different parts of the same problem, for example, focus stacks often combine an acute stimulant (caffeine), a calming complement (L-theanine), a precursor (L-tyrosine), and a cholinergic (Alpha-GPC). Avoid stacking blindly, adding three things at once means you cannot tell what worked. Introduce one substance, hold for 3-5 days, then add the next. Our Stack Builder tool shows you live cost rollup and pairwise interaction warnings.

Cycling means alternating periods of use with periods off, usually with the aim of limiting tolerance. Nootropics.com does not recommend cycling schedules. Where a substance's entry records tolerance, dependence or withdrawal, it appears among that substance's side effects and on its daily-use page. The Schedule planner lays out an on/off pattern you enter, next to those records.

Substances that act acutely (caffeine, L-tyrosine, modafinil) cross the blood-brain barrier and bind their targets within 30-60 minutes. Substances that work structurally, by increasing dendritic branching, modulating gene expression, or rebuilding membrane substrates, require 4-12 weeks of consistent dosing before the effect appears. Bacopa Monnieri, Lion's Mane, Omega-3, and the longevity compounds (NR/NMN, fisetin) fall into this category. The most common mistake is taking a 'slow' substance for two weeks, concluding it doesn't work, and stopping. Trust the chronic compounds for at least 8 weeks before evaluating.

Stop the most recently introduced substance for 3-5 days and see if the symptom resolves. Mild side effects (headache, mild GI upset, slight insomnia) often resolve with dose reduction or by addressing a missing co-factor, racetam headaches usually mean choline is too low; Bacopa GI discomfort usually resolves by week 2. Stop immediately and seek medical attention for: cardiovascular symptoms (palpitations, chest pain), severe persistent headache, sleep disruption lasting more than two nights, new psychiatric symptoms, neurological symptoms (tremor, vision changes, numbness), or any rash. Reporting suspected supplement adverse events to FDA MedWatch (US) helps regulators identify problem products.

Yes, and many users underestimate this. Examples worth knowing: modafinil reduces the effectiveness of estrogen-based contraceptives; rhodiola has mild MAO-A inhibition and shouldn't be combined with SSRIs or 5-HTP; ashwagandha can elevate T4 and is contraindicated in hyperthyroidism; vitamin K2 antagonises warfarin; omega-3 and ginkgo have additive blood-thinning effects with anticoagulants; saffron, 5-HTP, and tryptophan all carry serotonin-syndrome risk with SSRIs. Use our Interaction Checker for substance-substance pairs and discuss any new compound with the prescriber who knows your full medication list.

Default position: assume not safe unless your prescriber explicitly clears it. Pregnancy and breastfeeding are categorically excluded from supplement RCTs for ethical reasons, so we lack the data to make affirmative safety claims. Caffeine is well-studied and considered acceptable in moderation (under 200mg/day); omega-3 (DHA particularly) is actively encouraged. Almost everything else, racetams, peptides, prescription cognitive enhancers, most adaptogens, melatonin, should be discontinued. Discuss any supplement with your obstetrician or midwife.

Look for: third-party certificates of analysis (COAs) for each batch, transparent sourcing, USA or EU manufacturing, clear return policy, and a multi-year track record. The vendor's marketing language is a tell, "clinical-grade," "FDA-approved" (no supplement is FDA-approved), and aggressive disease claims are red flags. We list a small directory of vendors we have used or vetted at nootropics.com/vendors, with notes on why we include each. For racetams and peptides specifically, vendor selection matters far more than for commodity supplements, counterfeits and underdosed products are common.

For commodity substances (creatine, magnesium, omega-3, B-vitamins, ashwagandha extract), the cheapest reputable brand with a current COA is fine. Spend more on: the specific extract that was studied (KSM-66 ashwagandha, Magtein magnesium L-threonate, Meriva curcumin, Sharp-PS phosphatidylserine), products requiring tight quality control (modafinil, prescription only, and most peptides), and forms with measurable bioavailability differences (ubiquinol over ubiquinone CoQ10 for users over 50, phytosome curcumin over plain turmeric). Use our Cost Analyzer to filter stacks by daily-budget caps.

When you click a vendor link from our site and purchase, we may receive a small commission at no extra cost to you. We disclose affiliate links inline with an Ad badge near the link and in the footer and disclaimer pages. The affiliate relationship does not change our editorial conclusions: our scoring rubric is published and applied consistently, and we will publish negative findings about a vendor we have an affiliate relationship with. If we recommend something, it is because the evidence supports it, not because the commission is higher.

The Advisor at /tools/ask is powered by a large-language model (Anthropic Claude) and our curated substance catalog. When you ask a question, the model receives a compact summary of our 110-substance dataset as system context and answers based on that plus its general training. The model can be wrong, especially on edge cases and new research; always cross-check claims against the underlying substance page and the cited literature. Your messages are sent to Anthropic for processing, see the privacy policy for details. We require a one-time consent acknowledgement before the chat unlocks.

The minimum needed to operate: your email if you subscribe or sign in, pseudonymous Google Analytics data (off until you accept in the EU, UK and Switzerland; elsewhere off if you choose Essential only or send Global Privacy Control), affiliate click metadata, and Stripe billing identifiers if you have a paid subscription. We do not sell or share personal data with advertisers. The Daily Tracker stores entries in your browser only, we do not see them. Full detail is in the privacy policy, which covers GDPR, CCPA, and Australian Privacy Principles disclosures. Email [email protected] to request access, export, or deletion of your data.

Newsletter: click the unsubscribe link in any email, or email [email protected]. Account (if you have one): email [email protected] from the email address on file with subject "Delete my account." We respond within 30 days and confirm deletion in writing. We retain Stripe billing identifiers for active vendor subscriptions and for 7 years thereafter for tax record-keeping; other data is deleted on request.

If you have a clinical ADHD diagnosis, prescription stimulants (methylphenidate, amphetamine) and modafinil are first-line and the evidence is overwhelming. No supplement stack matches them. That said, complementary support is well-evidenced: high-EPA omega-3 has consistent RCT data; zinc supplementation helps when baseline is low (common in ADHD populations); L-tyrosine supports the catecholamines the medication is targeting; saffron has surprising non-inferiority evidence vs methylphenidate at low doses in pediatric trials. Do not stop prescribed medication to try supplements, work with your prescriber.

Every racetam (piracetam, aniracetam, oxiracetam, phenylpiracetam, pramiracetam) increases acetylcholine turnover. Without supplemental choline, the brain runs short of substrate and the most common side effect, headache, appears. The fix is reliable: pair every racetam dose with 300-600mg Alpha-GPC or 250-500mg CDP-Choline. This single pairing prevents most first-time racetam complaints. If you take a racetam and get a headache, raise the choline source before reducing the racetam dose.

"Smart drugs" is a loose term that usually refers to prescription cognitive enhancers, modafinil, methylphenidate, amphetamine, that produce strong acute effects on attention and wakefulness. Racetams are a family of synthetic compounds (Giurgea's original nootropic class) that work through different mechanisms (AMPA/NMDA modulation, cholinergic facilitation) at much lower potency than prescription stimulants. Racetam effects are subtle and chronic; smart-drug effects are pronounced and acute. The risk profiles differ accordingly, racetams have a much wider safety margin but much smaller effect size.